Immunization, Hib3 in Gambia
Gambia: Immunization, Hib3 was 80.0% in 2024. ▼ Falling
Immunization, Hib3 in Gambia, 1998–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Gambia is 80.0%, measured in 2024.
The figure is down 4.8% on the previous year and down 16.7% over ten years.
Over the whole period, immunization, hib3 in Gambia peaked at 99.0% in 2009 and was at its lowest, 79.0%, in 2022.
Gambia ranks 142nd of 191 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 27 years of available data.
Immunization, Hib3 in Gambia, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1998 | 97.0% | — |
| 1999 | 94.0% | -3.1% |
| 2000 | 90.0% | -4.3% |
| 2001 | 87.0% | -3.3% |
| 2002 | 89.0% | +2.3% |
| 2003 | 91.0% | +2.2% |
| 2004 | 93.0% | +2.2% |
| 2005 | 95.0% | +2.2% |
| 2006 | 95.0% | +0.0% |
| 2007 | 94.0% | -1.1% |
| 2008 | 97.0% | +3.2% |
| 2009 | 99.0% | +2.1% |
| 2010 | 97.0% | -2.0% |
| 2011 | 96.0% | -1.0% |
| 2012 | 98.0% | +2.1% |
| 2013 | 97.0% | -1.0% |
| 2014 | 96.0% | -1.0% |
| 2015 | 97.0% | +1.0% |
| 2016 | 95.0% | -2.1% |
| 2017 | 92.0% | -3.2% |
| 2018 | 93.0% | +1.1% |
| 2019 | 88.0% | -5.4% |
| 2020 | 85.0% | -3.4% |
| 2021 | 82.0% | -3.5% |
| 2022 | 79.0% | -3.7% |
| 2023 | 84.0% | +6.3% |
| 2024 | 80.0% | -4.8% |
Gambia compared with similar countries
- Gambia's 80.0% is above the median for low income countries, which is 73.0%, 1.1× the median. (25 countries reporting)
- Gambia's 80.0% is below the median for Sub-Saharan Africa, which is 82.5%, 97% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 95.5% | 94.0% | 97.0% | 2 |
| 2000s | 93.0% | 87.0% | 99.0% | 10 |
| 2010s | 94.9% | 88.0% | 98.0% | 10 |
| 2020s | 82.0% | 79.0% | 85.0% | 5 |
Countries ranked near Gambia
More health data for Gambia
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,044 deaths per 1,000 people (2090)
- Number of infants who die before age 1 700 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.9696 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0686 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9636 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Gambia?
- Immunization, hib3 in Gambia was 80.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Gambia?
- The highest recorded value was 99.0% in 2009.
- What is the lowest immunization, hib3 recorded in Gambia?
- The lowest recorded value was 79.0% in 2022.
- How does Gambia rank for immunization, hib3?
- Gambia ranks 142nd out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Gambia?
- Over the last ten years it is down 16.7%. The long-run trend across the full record is falling.
- Where does this Gambia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 27 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.